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  In order to evaluate effectiveness of cefoperazone （CPZ） in the treatrnent of the non－gonorrheal
infections of male urethral region， the clinical studies were carried out． CPZ was administered by
one－shot injection to 13 patients in daily dose of lg at once for 5 days． ln the treatment of bacterial
infections except for the non－specific urethritis， the overall efficacy rate in 13 cases was 920／o， i．e．， ex－
cellent in 4 cases， good in 8 cases and poor ’in 1 case．
  The effective rate in 7 patients with prostatitis was 1000／，， i．e．， excellent in 3 cases and good in
4 cases， and that rate in 6 patients with secondary non－gonorrheal urethritis was 830／．， i．e．， excellent
in 1 case， good in 4 cases and poor in 1 case．
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0      投与終了後，SMX－
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   BPHのTUR出頬 効   MIc：o．2”3／me
   BPHのopen prostatectomy後．有 効   MIC二3．13μ9／解
   前立腺癌のTUR後刻 効   MIC ：12，sn3／me
     前立腺癌を合併｛一） 著 効
     MIC ： O．78 ge S／nte
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